Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(20%)

Results Posted

50%(1 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_2

20%

Ph phase_4

20%

Ph phase_3

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

3(60.0%)

Phase 4Post-market surveillance

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Other(1)

Detailed Status

Completed2

Recruiting1

Terminated1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (20.0%)

Phase 33 (60.0%)

Phase 41 (20.0%)

Trials by Status

recruiting120%

terminated120%

unknown120%

completed240%

Recent Activity

1 active trials

Showing 5 of 5

recruitingphase_3

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

NCT00495092

unknownphase_4

Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence

NCT00495183

Clinical Trials (5)

Showing 5 of 5 trials

NCT04945213Phase 3

Biperiden Trial for Epilepsy Prevention

Recruiting

NCT01251393Phase 3

Cocaine/Crack and Reduction of Compulsion With Biperiden

Completed

NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated

NCT00495092Phase 2

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

Completed

NCT00495183Phase 4

Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5